MC869A1 - Furanosyl-aminopurines et médicament contenant ces substances - Google Patents

Furanosyl-aminopurines et médicament contenant ces substances

Info

Publication number
MC869A1
MC869A1 MC923A MC923A MC869A1 MC 869 A1 MC869 A1 MC 869A1 MC 923 A MC923 A MC 923A MC 923 A MC923 A MC 923A MC 869 A1 MC869 A1 MC 869A1
Authority
MC
Monaco
Prior art keywords
formula
purine
compounds
radical
amino
Prior art date
Application number
MC923A
Other languages
English (en)
French (fr)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MC869A1 publication Critical patent/MC869A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MC923A 1969-11-17 1970-11-10 Furanosyl-aminopurines et médicament contenant ces substances MC869A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87744369A 1969-11-17 1969-11-17

Publications (1)

Publication Number Publication Date
MC869A1 true MC869A1 (fr) 1971-09-28

Family

ID=25369972

Family Applications (1)

Application Number Title Priority Date Filing Date
MC923A MC869A1 (fr) 1969-11-17 1970-11-10 Furanosyl-aminopurines et médicament contenant ces substances

Country Status (26)

Country Link
US (1) US3666856A (cs)
JP (1) JPS5429520B1 (cs)
AT (1) AT309696B (cs)
BE (1) BE759011A (cs)
BR (1) BR6915136D0 (cs)
CA (1) CA967564A (cs)
CH (2) CH555344A (cs)
CS (1) CS181701B2 (cs)
DE (1) DE2056327C2 (cs)
DK (1) DK128117B (cs)
ES (2) ES385590A1 (cs)
FI (1) FI54315C (cs)
FR (1) FR2073364B1 (cs)
GB (2) GB1338905A (cs)
HU (1) HU163812B (cs)
IE (1) IE34737B1 (cs)
IL (1) IL35658A (cs)
LU (1) LU62071A1 (cs)
MC (1) MC869A1 (cs)
NL (1) NL171589C (cs)
NO (1) NO128156B (cs)
PL (1) PL81167B1 (cs)
SE (1) SE385374B (cs)
YU (2) YU35033B (cs)
ZA (1) ZA707722B (cs)
ZM (1) ZM12970A1 (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
GB1562899A (en) * 1975-06-17 1980-03-19 Wellcome Found Pharmaceutical compositions containing substituted 9-( -d-arabnofuranosyl)purine-5'-phosphate and salts thereof
US4210745A (en) * 1978-01-04 1980-07-01 The United States Of America As Represented By The Department Of Health, Education And Welfare Procedure for the preparation of 9-β-D-arabinofuranosyl-2-fluoroadenine
DE3319282A1 (de) * 1983-05-27 1984-11-29 Gödecke AG, 1000 Berlin Verwendung von adenosin bei der behandlung von herpes
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
CA1339964C (en) * 1988-03-16 1998-07-21 Dennis A. Carson Substituted adenine derivatives useful as therapeutic agents
US5292725A (en) * 1988-08-25 1994-03-08 Prendergast Patrick T Administering particular compounds against various parasites, mycoplasmas, other indications and other infections
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
US5681941A (en) * 1990-01-11 1997-10-28 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
US5308837A (en) * 1990-08-22 1994-05-03 Merrell Dow Pharmaceuticals Inc. 5'-amine substituted adenosine analogs as immunosuppressants
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US6232463B1 (en) 1997-10-09 2001-05-15 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
US6303617B1 (en) 1998-05-04 2001-10-16 Neotherapeutics, Inc. Serotonin-like 9-substituted hypoxanthine and methods of use
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
WO2002004448A2 (en) 2000-07-07 2002-01-17 Neotherapeutics, Inc. Methods for treatment of drug-induced peripheral neuropathy and related conditions
US6759427B2 (en) 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CN105237602B (zh) * 2015-06-25 2018-05-18 新乡学院 一种2-氨基阿糖腺苷的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1070413A (en) * 1962-11-15 1967-06-01 Sankyo Co A process for preparing purine and pyrimidine nucleosides
US3407191A (en) * 1966-08-29 1968-10-22 Lilly Co Eli Adamantoate esters of nucleosides
JPH1097965A (ja) * 1996-09-20 1998-04-14 Sony Corp 生産管理方法

Also Published As

Publication number Publication date
NL171589B (nl) 1982-11-16
NO128156B (cs) 1973-10-08
IL35658A0 (en) 1971-01-28
ES413787A1 (es) 1976-01-16
GB1338905A (en) 1973-11-28
JPS5429520B1 (cs) 1979-09-25
IE34737B1 (en) 1975-08-06
BE759011A (fr) 1971-05-17
ZA707722B (en) 1972-06-28
CH555344A (de) 1974-10-31
NL171589C (nl) 1983-04-18
DK128117B (da) 1974-03-04
AT309696B (de) 1973-08-27
GB1338906A (en) 1973-11-28
FR2073364B1 (cs) 1974-03-22
HU163812B (cs) 1973-10-27
ZM12970A1 (en) 1972-07-21
YU280670A (en) 1979-12-31
PL81167B1 (cs) 1975-08-30
CH555833A (de) 1974-11-15
SE385374B (sv) 1976-06-28
FI54315B (fi) 1978-07-31
YU35033B (en) 1980-06-30
LU62071A1 (cs) 1971-08-12
IL35658A (en) 1974-10-22
FR2073364A1 (cs) 1971-10-01
CA967564A (en) 1975-05-13
US3666856A (en) 1972-05-30
NL7016766A (cs) 1971-05-19
CS181701B2 (en) 1978-03-31
DE2056327A1 (de) 1971-06-03
ES385590A1 (es) 1973-10-01
YU201978A (en) 1979-12-31
IE34737L (en) 1971-05-17
FI54315C (fi) 1978-11-10
DE2056327C2 (de) 1984-10-11
BR6915136D0 (pt) 1973-04-19
YU35034B (en) 1980-06-30

Similar Documents

Publication Publication Date Title
MC869A1 (fr) Furanosyl-aminopurines et médicament contenant ces substances
EP0717748B1 (fr) Composes 2' ou 3'-deoxy- et 2', 3'-dideoxy-beta-l-pentofuranonucleosides, procede de preparation et application therapeutique, notamment anti-virale
MC1068A1 (fr) Derives de la purine et medicaments qui en contienprocede de preparation de derives de la purine nent
LU87414A1 (fr) Derives de l'adenosine
MC1174A1 (fr) Nouveaux nucleosides et procede pour leur preparation
MC1882A1 (fr) Composes anti-viraux
MC1968A1 (fr) Procede de preparation de composes antiviraux et procede de preparation de formulations pharmaceutiques les contenant
MC1935A1 (fr) Procedes pour la preparation d'arabinosides puriques substitues,de leurs derives pharmaceutiquement acceptables et de formulations pharmaceutiques les contenant
MC1846A1 (fr) Derives de pyrimidine
MC1915A1 (fr) Procédés pour la préparation de 2',3'-didésoxynucléosides et de formulations pharmaceutiques en contenant
FR2763953A1 (fr) Derives de 5'-desoxy-cytidine
LU81890A1 (fr) Nouvelles spiro-polycyclo-imidazolidinediones et compostion pharmaceutique les contenant
FR2531962A1 (fr) Nouveaux derives de la desoxyuridine, leur preparation et leur utilisation comme medicaments
WO1993015100A1 (fr) Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant
MC898A1 (fr) Composés organiques
MC1984A1 (fr) Derives de la purine
FR2574412A1 (fr) Procede de fabrication de derives de nucleosides utiles notamment comme agents anticancereux
MC1845A1 (fr) Derives de pyrimidine
WO1995018817A1 (fr) Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant
Chu et al. Nucleosides. 107. Synthesis of 5-(. beta.-D-arabinofuranosyl) isocytosine and related C-nucleosides
EP1438320A1 (fr) Nouveaux derives d'hydroxyalkyle indolocarbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MC1914A1 (fr) Nucleosides therapeutiques
MC1182A1 (fr) Procede de preparation de derives de la guanine
FR2566410A1 (fr) Nouveaux derives de l'acide diaminopimelique, leur procede de preparation et leur application en therapeutique
FR2563223A1 (fr) Nouveaux derives du pyrane ainsi que leur procede de preparation